Merck Entrance on Lansdale, PA

FDA Panel OKs First COVID Pill 'Molnupiravir' From Merck

FDA panel "narrowly' backs Merck's COVID pill known as molnupiravir.
Pfizer’s COVID Pill Cuts 89 Percent of Severe COVID Cases: Clinical Trial Results

Pfizer's COVID Pill Cuts 89 Percent of Severe COVID Cases: Clinical Trial Results

By Mary Webber
U.S. pharmaceutical company Pfizer has developed a COVID pill noting that it reduces the risk of severe COVID cases by 89 percent, according to the clinical trials of the company.
Most Read
  1. Tini Stoessel & Young Miko Aren't Hiding Anymore
  2. First Photos of Gisele Bündchen’s Baby Bump: A Cover-Worthy Mom-to-Be!
  3. The Best Places to Celebrate Halloween in the United States
  4. Tekashi 6ix9ine is Back in the Spotlight After Being Arrested Again—Will He Lose His Record Deal?
Real Time Analytics